Leen Kawas Details the Factors Behind High Drug Development Costs (and Presents Strategies to Address Them)

In the increasingly complex healthcare realm, a regular flow of drug introductions offers potential benefits to millions of patients. However, the biotech and pharmaceutical companies that develop these therapies do so at great expense. High drug development costs, and a multi-year development cycle, can stress the budgets of even well-capitalized firms.

Biotech expert Leen Kawas discussed the drivers of high drug development costs. She also offered strategies to streamline the process and reduce the strain on the developer’s financial resources.

Read the full article here: https://www.sfweekly.com/marketplace/leen-kawas-details-the-factors-behind-high-drug-development-costs-and-presents-strategies-to-address/article_5f223352-a20b-11ef-b398-07d584b23662.html